Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea
· Delayed Price · Currency is KRW 4,940.00
+60.00 (1.23%)
At close: Apr 29, 2026
Jin Yang Pharmaceutical Revenue
In the year 2025, Jin Yang Pharmaceutical had annual revenue of 120.69B KRW with 6.49% growth. Jin Yang Pharmaceutical had revenue of 30.32B in the quarter ending December 31, 2025, with 13.05% growth.
Revenue
120.69B
Revenue Growth
+6.49%
P/S Ratio
0.52
Revenue / Employee
548.57M
Employees
220
Market Cap
63.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 120.69B | 7.35B | 6.49% |
| Dec 31, 2024 | 113.33B | 19.22B | 20.42% |
| Dec 31, 2023 | 94.11B | 17.85B | 23.40% |
| Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
| Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kyung Nam Pharm | 56.18B |
| BL Pharmtech | 6.51B |
| Sinil Pharmaceutical | 80.56B |
| Korea Arlico Pharm | 201.20B |
| RP Bio | 136.22B |
| Optipharm.CO.,LTD | 22.34B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |
| Hwail Pharmaceutical | 107.87B |